Ciromed GmbH

Leverkusen, DEImpact-drivenPrivate SectorHealthcareScience & Research

Impact2Sustainability Goals

LocationLeverkusen

About Ciromed GmbH

Ciromed GmbH is a Germany-based medical and research organization dedicated to advancing the treatment of dry age-related macular degeneration (AMD). The company operates as a specialized hub for ophthalmological innovation, focusing on the validation of non-invasive photobiomodulation (PBM) therapy. By coordinating large-scale clinical trials, such as the government-funded MACULIGHT study, Ciromed bridges the gap between research and practical medical application to improve patient outcomes.

Do you work at Ciromed GmbH?

baito is the job platform for meaningful jobs: more than 60,000 people look here every month. Your first job ad is half price.

This signs you up for our newsletter for employers. Unsubscribe any time. Privacy

Connect

Kununu

Sustainability Goals

Good Health & Well-Being

Innovation in Ophthalmology
Ciromed GmbH validates non-invasive photobiomodulation therapies to effectively slow the progression of age-related macular degeneration (AMD) in patients.
Digital Access to Diagnosis and Care
Through online self-tests and specialized resources, the organization enables patients to obtain early assessments and locate targeted medical care more effectively.

Industry, Innovation & Infrastructure

Bridging Research and Clinical Application
Serving as a key interface in the healthcare sector, Ciromed GmbH coordinates large-scale clinical trials and drives the evidence-based advancement of medical therapy protocols.

125 profile views

last 28 days

For employers

Job seekers are discovering Ciromed GmbH

Claim your profile on baito and get discovered by talent looking for purpose-driven work. Showcase your mission, culture, and benefits and turn visitors into applicants.

Free & takes 2 minutes

Claim Profile

Culture & Values

Showcase your culture and values to stand out from the crowd.

FAQs

What is the primary focus of Ciromed GmbH's work?

Ciromed GmbH is a medical and research-focused organization dedicated to the treatment of dry age-related macular degeneration (AMD). The company validates non-invasive photobiomodulation (PBM) therapies to help slow the progression of this eye disease.

What is the MACULIGHT study?

The MACULIGHT study is a multicenter clinical trial funded by the Federal Ministry for Research, Technology and Space (BMFTR). It investigates the efficacy of PBM home therapy in collaboration with leading German medical centers.